242 related articles for article (PubMed ID: 25320541)
1. Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.
Li MR; Zhang SH; Chao K; Liao XH; Yao JY; Chen MH; Zhong BH
World J Gastroenterol; 2014 Oct; 20(38):14010-7. PubMed ID: 25320541
[TBL] [Abstract][Full Text] [Related]
2. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases.
Zhang RN; Zheng RD; Mi YQ; Zhou D; Shen F; Chen GY; Zhu CY; Pan Q; Fan JG
Dig Dis Sci; 2016 Aug; 61(8):2284-2293. PubMed ID: 27059980
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.
Niu TH; Jiang M; Xin YN; Jiang XJ; Lin ZH; Xuan SY
World J Gastroenterol; 2014 Apr; 20(13):3655-62. PubMed ID: 24707151
[TBL] [Abstract][Full Text] [Related]
4. A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver disease.
Chen BF; Chien Y; Tsai PH; Perng PC; Yang YP; Hsueh KC; Liu CH; Wang YH
J Chin Med Assoc; 2021 Oct; 84(10):923-929. PubMed ID: 34108427
[TBL] [Abstract][Full Text] [Related]
5. [Association of single nucleotide polymorphism of SIRT1 and APOC3 with nonalcoholic fatty liver disease].
Song X; Song C; Fan L; Ma Q; Mao J; Xu W; Li X
Wei Sheng Yan Jiu; 2017 Jul; 46(4):527-532. PubMed ID: 29903170
[TBL] [Abstract][Full Text] [Related]
6. Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.
Pan Q; Zhang RN; Wang YQ; Zheng RD; Mi YQ; Liu WB; Shen F; Chen GY; Lu JF; Zhu CY; Zhang SY; Chen YM; Sun WL; Fan JG
World J Gastroenterol; 2015 Jul; 21(28):8605-14. PubMed ID: 26229402
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein C3 gene polymorphisms in Southern Indian patients with nonalcoholic fatty liver disease.
Puppala J; Bhrugumalla S; Kumar A; Siddapuram SP; Viswa PD; Kondawar M; Akka J; Munshi A
Indian J Gastroenterol; 2014 Nov; 33(6):524-9. PubMed ID: 25319715
[TBL] [Abstract][Full Text] [Related]
8. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
[TBL] [Abstract][Full Text] [Related]
9. Relationship of SREBP-2 rs2228314 G>C polymorphism with nonalcoholic fatty liver disease in a Han Chinese population.
Wang Y; Tong J; Chang B; Wang BF; Zhang D; Wang BY
Genet Test Mol Biomarkers; 2014 Sep; 18(9):653-7. PubMed ID: 24992162
[TBL] [Abstract][Full Text] [Related]
10. Association between UCP3 gene polymorphisms and nonalcoholic fatty liver disease in Chinese children.
Xu YP; Liang L; Wang CL; Fu JF; Liu PN; Lv LQ; Zhu YM
World J Gastroenterol; 2013 Sep; 19(35):5897-903. PubMed ID: 24124336
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A5 gene polymorphisms are associated with non-alcoholic fatty liver disease.
Xu Y; Lu LL; Liu SS; Du SX; Zhu HL; Dong QJ; Xin YN
Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):214-219. PubMed ID: 29735301
[TBL] [Abstract][Full Text] [Related]
12. [AGT rs5051 gene polymorphism increases the risk of coronary heart disease in patients with non-alcoholic fatty liver disease in the Han Chinese population].
Dong MZ; Lin ZH; Liu SS; Xin YN; Xuan SY
Zhonghua Gan Zang Bing Za Zhi; 2021 Nov; 29(11):1095-1100. PubMed ID: 34933429
[No Abstract] [Full Text] [Related]
13. AGTR1 rs3772622 gene polymorphism increase the risk of nonalcoholic fatty liver disease patients suffer coronary artery disease in Northern Chinese Han population.
Liu Y; Lu LL; Yuan DX; Geng N; Xuan SY; Xin YN
Lipids Health Dis; 2016 Jun; 15():113. PubMed ID: 27342049
[TBL] [Abstract][Full Text] [Related]
14. Association between APOC3 polymorphisms and non-alcoholic fatty liver disease risk: a meta-analysis.
Wang J; Ye C; Fei S
Afr Health Sci; 2020 Dec; 20(4):1800-1808. PubMed ID: 34394242
[TBL] [Abstract][Full Text] [Related]
15. Association of Sst I polymorphism in apolipoprotein C3 gene with hypertriglyceridaemia in coronary atherosclerotic heart disease and type II diabetes mellitus in Chinese population.
Liu HK; Li XF; Zhang SZ; Ren Y; Yong-Xin ; Liu YQ; Wang CT; Chen X; Hu YM; Zhang L
Yi Chuan Xue Bao; 2005 Jan; 32(1):11-8. PubMed ID: 15715433
[TBL] [Abstract][Full Text] [Related]
16. Association of patatin-like phospholipase domain-containing protein 3 gene polymorphisms with susceptibility of nonalcoholic fatty liver disease in a Han Chinese population.
Song G; Xiao C; Wang K; Wang Y; Chen J; Yu Y; Wang Z; Deng G; Sun X; Zhong L; Zhou C; Qi X; Wang S; Peng Z; Wang X
Medicine (Baltimore); 2016 Aug; 95(33):e4569. PubMed ID: 27537584
[TBL] [Abstract][Full Text] [Related]
17. Relationship between
Dong M; Liu S; Wang M; Wang Y; Xin Y; Xuan S
J Int Med Res; 2021 Jul; 49(7):3000605211019263. PubMed ID: 34275374
[TBL] [Abstract][Full Text] [Related]
18. Association between the -455T>C promoter polymorphism of the APOC3 gene and the metabolic syndrome in a multi-ethnic sample.
Pollex RL; Ban MR; Young TK; Bjerregaard P; Anand SS; Yusuf S; Zinman B; Harris SB; Hanley AJ; Connelly PW; Huff MW; Hegele RA
BMC Med Genet; 2007 Dec; 8():80. PubMed ID: 18096054
[TBL] [Abstract][Full Text] [Related]
19. [Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease].
Niu T; Jiang M; Liu H; Jiang X; Lin Z; Zhang M; Wang J; Geng N; Xin Y; Xuan S
Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):374-9. PubMed ID: 25180874
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
